Literature DB >> 29298491

Is Magnetic Resonance Imaging Detection of Kidney Iron Deposition Increased in Haptoglobin 2-2 Genotype Carriers with Type 1 Diabetes?

Tina Costacou1, Trevor J Orchard1, Chan Hong Moon2, Kyongtae T Bae2, Linda Fried1,3,4, Rhobert W Evans1.   

Abstract

Haptoglobin's (Hp) main role is to bind free hemoglobin (Hb), reducing its oxidative potential. The Hp-Hb complex formed is cleared from the circulation by macrophage receptor CD163. In diabetes, impaired Hp 2-2-Hb CD163 clearance and abnormal glomerular permeability allow the large Hp 2-2-Hb complex to cross the barrier, where its redox active iron leads to cellular toxicity. Although Hp 2-2 predicts renal function decline, whether renal iron deposition differs by Hp is unknown. We used renal quantitative T2* magnetic resonance imaging to estimate iron level in the cortex and medullar of type 1 diabetes (T1D) adults [15 Hp 1-1 and 15 Hp 2-2 carriers of similar age (53 years), duration (45 years), and gender]. Total kidney iron level was estimated as the sum of the cortex and medullar iron. Albuminuria was defined as urinary albumin to creatinine ratio >30 mg/g in two of three samples. Total kidney iron did not differ by gender or Hp but was higher in those with albuminuria (p = 0.05), an association confined to Hp 2-2 carriers (p = 0.04 vs. p = 0.51 in Hp 1-1). These data lead to the hypothesis that kidney iron deposition is increased among Hp 2-2 carriers with albuminuria in T1D. Antioxid. Redox Signal. 29, 735-741.

Entities:  

Keywords:  MRI; albuminuria; haptoglobin genotype; iron; kidney function; type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29298491      PMCID: PMC6067098          DOI: 10.1089/ars.2017.7444

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin.

Authors:  Jakub Gburek; Pierre J Verroust; Thomas E Willnow; John C Fyfe; Wojciech Nowacki; Christian Jacobsen; Søren K Moestrup; Erik I Christensen
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

2.  Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.

Authors:  Tina Costacou; Andrew P Levy; Rachel G Miller; Janet Snell-Bergeon; Rabea Asleh; Dan Farbstein; Catherine E Fickley; Georgia Pambianco; Rona de la Vega; Rhobert W Evans; Trevor J Orchard
Journal:  Acta Diabetol       Date:  2015-05-24       Impact factor: 4.280

3.  Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.

Authors:  Farid M Nakhoul; Rachel Miller-Lotan; Hoda Awad; Rabea Asleh; Kheir Jad; Nakhoul Nakhoul; Roy Asaf; Niroz Abu-Saleh; Andrew P Levy
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-28

Review 4.  Biological and clinical significance of haptoglobin polymorphism in humans.

Authors:  M R Langlois; J R Delanghe
Journal:  Clin Chem       Date:  1996-10       Impact factor: 8.327

5.  Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.

Authors:  Rabea Asleh; Farid M Nakhoul; Rachel Miller-Lotan; Hoda Awad; Dan Farbstein; Nina S Levy; Nakhoul Nakhoul; Theodore C Iancu; Irena Manov; Michael Laue; Maret G Traber; Katie M Lebold; Andrew P Levy
Journal:  Free Radic Biol Med       Date:  2012-06-27       Impact factor: 7.376

Review 6.  Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.

Authors:  Edmund J Lewis; Xiulong Xu
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

7.  Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset.

Authors:  Tina Costacou; Trevor J Orchard
Journal:  Diabetes Care       Date:  2017-09-20       Impact factor: 19.112

8.  Haptoglobin genotype and renal function decline in type 1 diabetes.

Authors:  Tina Costacou; Robert E Ferrell; Demetrius Ellis; Trevor J Orchard
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

9.  Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.

Authors:  Trevor J Orchard; Wanjie Sun; Patricia A Cleary; Saul M Genuth; John M Lachin; Paula McGee; Andrew D Paterson; Philip Raskin; Yefim Anbinder; Andrew P Levy
Journal:  Diabetes       Date:  2013-06-12       Impact factor: 9.461

  9 in total
  2 in total

1.  The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study.

Authors:  Jinghui Ju; Erin L Tomaszewski; Trevor J Orchard; Rhobert W Evans; Eleanor Feingold; Tina Costacou
Journal:  Acta Diabetol       Date:  2019-09-16       Impact factor: 4.280

2.  Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.

Authors:  Rabea Asleh; Alexandros Briasoulis; Elliot M Berinstein; Joshua B Wiener; Mohan Palla; Sudhir S Kushwaha; Andrew P Levy
Journal:  Pharmgenomics Pers Med       Date:  2018-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.